Preface |
|
xi | |
Acknowledgements |
|
xiii | |
|
|
1 | (4) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
3 | (2) |
|
|
3 | (2) |
|
|
5 | (9) |
|
Normal mucosal architecture |
|
|
5 | (1) |
|
|
5 | (4) |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (3) |
|
|
11 | (3) |
|
Assessment of abnormalities: diagnostic signposts |
|
|
14 | (42) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
16 | (2) |
|
|
18 | (1) |
|
|
18 | (1) |
|
Mucosal crypt architecture |
|
|
19 | (10) |
|
|
29 | (4) |
|
|
33 | (11) |
|
|
44 | (5) |
|
|
49 | (1) |
|
|
50 | (2) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (3) |
|
|
53 | (3) |
|
|
56 | (34) |
|
|
56 | (1) |
|
Acute bacterial diarrhoeas/infective colitis and proctitis |
|
|
57 | (8) |
|
|
65 | (1) |
|
Sexually transmitted diseases |
|
|
66 | (3) |
|
Intestinal spirochaetosis |
|
|
69 | (1) |
|
|
70 | (4) |
|
|
74 | (3) |
|
|
77 | (2) |
|
|
79 | (3) |
|
|
82 | (8) |
|
|
82 | (8) |
|
|
90 | (23) |
|
|
90 | (1) |
|
|
91 | (10) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
102 | (4) |
|
Inflammatory polyps ('pseudopolyps') |
|
|
106 | (1) |
|
Fulminant acute colitis (toxic dilatation) |
|
|
106 | (1) |
|
|
107 | (1) |
|
|
107 | (6) |
|
|
107 | (6) |
|
|
113 | (11) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (4) |
|
|
118 | (1) |
|
|
119 | (1) |
|
|
120 | (1) |
|
Colonoscopic biopsy in Crohn's disease |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
121 | (3) |
|
|
121 | (3) |
|
|
124 | (9) |
|
Introduction: clinical indications for pouch surgery |
|
|
124 | (1) |
|
Normal adaptive changes: ileal mucosa vs. residual rectal cuff mucosa |
|
|
124 | (1) |
|
Inflammation and pouchitis |
|
|
125 | (1) |
|
Risk factors for pouchitis |
|
|
126 | (2) |
|
|
128 | (1) |
|
Differential diagnosis of pouchitis |
|
|
128 | (2) |
|
|
130 | (3) |
|
|
131 | (2) |
|
|
133 | (13) |
|
Introduction: pseudomembranous colitis, antibiotic-associated colitis and diarrhoea |
|
|
133 | (1) |
|
|
134 | (6) |
|
Problems in the differential diagnosis |
|
|
140 | (1) |
|
Clostridium difficile and its toxin |
|
|
140 | (2) |
|
The pathologist's role in the diagnosis of pseudomembranous colitis |
|
|
142 | (1) |
|
|
142 | (4) |
|
|
142 | (4) |
|
Microscopic colitis -- collagenous colitis, lymphocytic colitis and their variants |
|
|
146 | (22) |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
148 | (13) |
|
Aetiology and pathogenesis |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
163 | (5) |
|
|
163 | (5) |
|
|
168 | (14) |
|
|
168 | (1) |
|
Anatomical considerations |
|
|
168 | (1) |
|
|
169 | (2) |
|
Natural history of ischaemic bowel disease |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
172 | (3) |
|
Difficulties with diagnosis |
|
|
175 | (1) |
|
|
176 | (1) |
|
Necrotizing colitis syndromes |
|
|
177 | (5) |
|
|
177 | (5) |
|
|
182 | (20) |
|
|
182 | (2) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
185 | (6) |
|
|
191 | (1) |
|
Graft-versus-host disease |
|
|
192 | (2) |
|
|
194 | (1) |
|
Colitis caused by bowel preparation and instrumentation |
|
|
194 | (1) |
|
|
195 | (1) |
|
Melanosis coli and laxative abuse |
|
|
195 | (7) |
|
|
196 | (6) |
|
The differential diagnosis of inflammatory bowel disease |
|
|
202 | (31) |
|
|
203 | (1) |
|
Significance of the normal biopsy |
|
|
203 | (1) |
|
|
204 | (5) |
|
Major disease entities: ulcerative colitis vs. Crohn's disease vs. infection |
|
|
209 | (3) |
|
|
212 | (7) |
|
The terminal ileal biopsy |
|
|
219 | (5) |
|
Backwash ileitis and ileal complications of ulcerative colitis |
|
|
224 | (1) |
|
Ileal nodular lymphoid hyperplasia |
|
|
225 | (1) |
|
|
226 | (7) |
|
|
226 | (7) |
|
|
233 | (15) |
|
|
233 | (1) |
|
|
233 | (2) |
|
Congenital megacolon: neuronal dysplasias, including Hirschsprung's disease |
|
|
235 | (7) |
|
Idiopathic megacolon of childhood |
|
|
242 | (1) |
|
|
242 | (2) |
|
Features associated with megacolon |
|
|
244 | (4) |
|
|
246 | (2) |
|
Neoplasia in the colon and rectum and its classification |
|
|
248 | (3) |
|
|
248 | (3) |
|
|
250 | (1) |
|
|
251 | (41) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
253 | (7) |
|
|
260 | (4) |
|
|
264 | (2) |
|
|
266 | (2) |
|
|
268 | (3) |
|
Mucosal prolapse syndrome, including inflammatory cap polyp and inflammatory myoglandular polyp |
|
|
271 | (4) |
|
The Cronkhite--Canada syndrome |
|
|
275 | (1) |
|
Problems in the diagnosis of mucosal polyps: differential diagnosis |
|
|
275 | (1) |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
279 | (3) |
|
Cowden's (multiple hamartoma) syndrome |
|
|
282 | (1) |
|
|
282 | (1) |
|
Heterotopic gastric mucosa |
|
|
282 | (2) |
|
|
284 | (1) |
|
|
285 | (7) |
|
|
286 | (6) |
|
The diagnosis of malignancy |
|
|
292 | (9) |
|
|
292 | (1) |
|
Overdiagnosis of malignancy |
|
|
293 | (1) |
|
The stroma of invasive adenocarcinoma |
|
|
293 | (2) |
|
Focal carcinoma in adenomatous polyps ('malignant polyps') |
|
|
295 | (3) |
|
Decisions when reporting biopsies of neoplastic tissue |
|
|
298 | (3) |
|
|
300 | (1) |
|
Dysplasia in inflammatory bowel disease |
|
|
301 | (29) |
|
|
301 | (1) |
|
|
302 | (1) |
|
Patients at risk and cancer incidence |
|
|
303 | (2) |
|
The reliability of dysplasia in cancer surveillance |
|
|
305 | (1) |
|
The macroscopic lesion in dysplasia |
|
|
306 | (1) |
|
Histological recognition and classification of dysplasia |
|
|
307 | (9) |
|
|
316 | (1) |
|
Other stains and methodologies |
|
|
316 | (1) |
|
|
317 | (1) |
|
Implication of the pathologist's report |
|
|
317 | (2) |
|
The sporadic adenoma and dysplasia-associated lesion or mass in ulcerative colitis |
|
|
319 | (4) |
|
Failure to find a lesion following recommendation for surgery |
|
|
323 | (7) |
|
|
323 | (7) |
|
|
330 | (21) |
|
|
330 | (7) |
|
Endocrine cell (carcinoid) tumours |
|
|
337 | (3) |
|
|
340 | (2) |
|
|
342 | (3) |
|
|
345 | (6) |
|
|
347 | (4) |
|
|
351 | (26) |
|
|
351 | (1) |
|
|
352 | (9) |
|
Tumours of the anal canal |
|
|
361 | (7) |
|
|
368 | (9) |
|
|
374 | (3) |
|
|
377 | (18) |
|
Angiodysplasia and other primary vascular lesions |
|
|
377 | (3) |
|
Cystic pneumatosis (pneumatosis cystoides intestinalis, pneumatosis coli) |
|
|
380 | (1) |
|
|
380 | (1) |
|
Chronic granulomatous disease of childhood |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
382 | (1) |
|
Ceroid lipofuscinosis (including Batten's disease) |
|
|
383 | (1) |
|
|
383 | (2) |
|
Cronkhite-Canada syndrome |
|
|
385 | (1) |
|
Mucoviscidosis (cystic fibrosis) |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
387 | (1) |
|
Primary immunodeficiency syndromes |
|
|
387 | (1) |
|
|
388 | (1) |
|
|
389 | (6) |
|
|
389 | (6) |
Index |
|
395 | |